» Articles » PMID: 28436309

Corticotropin-releasing Hormone-binding Protein and Stress: from Invertebrates to Humans

Overview
Journal Stress
Publisher Informa Healthcare
Specialties Biology
Neurology
Date 2017 Apr 25
PMID 28436309
Citations 50
Authors
Affiliations
Soon will be listed here.
Abstract

Corticotropin-releasing hormone (CRH) is a key regulator of the stress response. This peptide controls the hypothalamic-pituitary-adrenal (HPA) axis as well as a variety of behavioral and autonomic stress responses via the two CRH receptors, CRH-R1 and CRH-R2. The CRH system also includes an evolutionarily conserved CRH-binding protein (CRH-BP), a secreted glycoprotein that binds CRH with subnanomolar affinity to modulate CRH receptor activity. In this review, we discuss the current literature on CRH-BP and stress across multiple species, from insects to humans. We describe the regulation of CRH-BP in response to stress, as well as genetic mouse models that have been utilized to elucidate the in vivo role(s) of CRH-BP in modulating the stress response. Finally, the role of CRH-BP in the human stress response is examined, including single nucleotide polymorphisms in the human CRHBP gene that are associated with stress-related affective disorders and addiction. Lay summary The stress response is controlled by corticotropin-releasing hormone (CRH), acting via CRH receptors. However, the CRH system also includes a unique CRH-binding protein (CRH-BP) that binds CRH with an affinity greater than the CRH receptors. In this review, we discuss the role of this highly conserved CRH-BP in regulation of the CRH-mediated stress response from invertebrates to humans.

Citing Articles

Innovative Dual mRNA-Lipid Nanoparticle Therapy Targeting CRHBP and CFHR3 for Enhanced Treatment of Hepatocellular Carcinoma.

Fu T, Zhou B, Li Y, Liu W, Xie Y, Mo Z Int J Nanomedicine. 2024; 19:13183-13199.

PMID: 39664759 PMC: 11633302. DOI: 10.2147/IJN.S498065.


CRHBP, a novel multiple cancer biomarker connected with better prognosis and anti-tumorigenicity.

Yoo W, Choi H, Lee J, Lee Y, Park K, Noh K Cancer Cell Int. 2024; 24(1):391.

PMID: 39614295 PMC: 11607943. DOI: 10.1186/s12935-024-03562-4.


Multi-organ transcriptome atlas of a mouse model of relative energy deficiency in sport.

van Rosmalen L, Zhu J, Maier G, Gacasan E, Lin T, Zhemchuzhnikova E Cell Metab. 2024; 36(9):2015-2037.e6.

PMID: 39232281 PMC: 11378950. DOI: 10.1016/j.cmet.2024.08.001.


Stress, hypothalamic-pituitary-adrenal axis, hypothalamic-pituitary-gonadal axis, and aggression.

Mbiydzenyuy N, Qulu L Metab Brain Dis. 2024; 39(8):1613-1636.

PMID: 39083184 PMC: 11535056. DOI: 10.1007/s11011-024-01393-w.


CRF binding protein activity in the hypothalamic paraventricular nucleus is essential for stress adaptations and normal maternal behaviour in lactating rats.

Sanson A, Krieg P, Schramm M, Kellner K, Maloumby R, Klampfl S Neurobiol Stress. 2024; 30:100631.

PMID: 38601362 PMC: 11004997. DOI: 10.1016/j.ynstr.2024.100631.


References
1.
McEwen B . Central effects of stress hormones in health and disease: Understanding the protective and damaging effects of stress and stress mediators. Eur J Pharmacol. 2008; 583(2-3):174-85. PMC: 2474765. DOI: 10.1016/j.ejphar.2007.11.071. View

2.
Hsu S, Hsueh A . Human stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor. Nat Med. 2001; 7(5):605-11. DOI: 10.1038/87936. View

3.
McClennen S, Seasholtz A . Transcriptional regulation of corticotropin-releasing hormone-binding protein gene expression in astrocyte cultures. Endocrinology. 1999; 140(9):4095-103. DOI: 10.1210/endo.140.9.6978. View

4.
Kishimoto T, Pearse 2nd R, Lin C, Rosenfeld M . A sauvagine/corticotropin-releasing factor receptor expressed in heart and skeletal muscle. Proc Natl Acad Sci U S A. 1995; 92(4):1108-12. PMC: 42647. DOI: 10.1073/pnas.92.4.1108. View

5.
Davydow D, Kohen R, Hough C, Tracy J, Zatzick D, Katon W . A pilot investigation of the association of genetic polymorphisms regulating corticotrophin-releasing hormone with posttraumatic stress and depressive symptoms in medical-surgical intensive care unit survivors. J Crit Care. 2013; 29(1):101-6. PMC: 3865113. DOI: 10.1016/j.jcrc.2013.08.016. View